Not applicableStudy completedNCT06851065
What this trial is testing
Evaluate Luspatercept Treatment Patterns and Outcomes in Erythropoiesis-Stimulating Agents-Naïve Patients With Lower-Risk Myelodysplastic Syndromes in the United States
Who this might be right for
Myelodysplastic Syndromes
Bristol-Myers Squibb 418